SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cortex (Cor) [formerly CORX]
COR 359.22+2.0%Jan 30 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Lacelle who wrote (765)1/26/1999 1:08:00 AM
From: Tagore  Read Replies (2) of 1255
 
John,
Let's hope that virtue will be rewarded. The valuation is crazy since the company had to have received at least $10MM from the partnership since Simmon has stated that they received enough cash fortwo years. The delay in signing the deal did not have to do with the amount of $$, but they also got the rights to depression along with schizophrenia. Simmons is also excited about the results from the schizophrenia trial which may be reported in May unless the Dr. running the trial keeps adding patients.
Tagore
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News